Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.39975941 |
2 | negative regulation of cell killing (GO:0031342) | 6.75224859 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.75224859 |
4 | negative thymic T cell selection (GO:0045060) | 5.80897441 |
5 | negative T cell selection (GO:0043383) | 5.79168921 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.75838584 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.75205007 |
8 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.58475973 |
9 | cellular response to interleukin-15 (GO:0071350) | 5.58049002 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.50764322 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.50764322 |
12 | response to interleukin-15 (GO:0070672) | 5.50057492 |
13 | regulation of gamma-delta T cell activation (GO:0046643) | 5.42478418 |
14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.30259002 |
15 | positive thymic T cell selection (GO:0045059) | 5.21101082 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.94538153 |
17 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.92643892 |
18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78846358 |
19 | thymic T cell selection (GO:0045061) | 4.71827999 |
20 | positive T cell selection (GO:0043368) | 4.64799084 |
21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.56923178 |
22 | T cell selection (GO:0045058) | 4.41130409 |
23 | interferon-gamma production (GO:0032609) | 4.40878504 |
24 | regulation of regulatory T cell differentiation (GO:0045589) | 4.35001972 |
25 | leukocyte aggregation (GO:0070486) | 4.12541434 |
26 | T cell migration (GO:0072678) | 4.06718696 |
27 | positive regulation of isotype switching (GO:0045830) | 4.02135853 |
28 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.01372384 |
29 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.99305620 |
30 | positive regulation of humoral immune response (GO:0002922) | 3.98713899 |
31 | lymphocyte costimulation (GO:0031294) | 3.97505151 |
32 | T cell costimulation (GO:0031295) | 3.97432439 |
33 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.91234212 |
34 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.89860937 |
35 | B cell receptor signaling pathway (GO:0050853) | 3.85871892 |
36 | neutrophil activation involved in immune response (GO:0002283) | 3.85822430 |
37 | mature B cell differentiation (GO:0002335) | 3.82356160 |
38 | T cell receptor signaling pathway (GO:0050852) | 3.82068183 |
39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.79196378 |
40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.78206348 |
41 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.78206348 |
42 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.73916487 |
43 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.73916487 |
44 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.72006314 |
45 | positive regulation of B cell mediated immunity (GO:0002714) | 3.72006314 |
46 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.69729016 |
47 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.68618998 |
48 | regulation of T cell tolerance induction (GO:0002664) | 3.67347124 |
49 | positive regulation of DNA recombination (GO:0045911) | 3.67300460 |
50 | immunoglobulin mediated immune response (GO:0016064) | 3.63272815 |
51 | regulation of B cell differentiation (GO:0045577) | 3.57735695 |
52 | regulation of isotype switching (GO:0045191) | 3.57267033 |
53 | mast cell activation (GO:0045576) | 3.54753979 |
54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52786705 |
55 | T cell homeostasis (GO:0043029) | 3.50821987 |
56 | positive regulation of interleukin-2 production (GO:0032743) | 3.49185673 |
57 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.46767176 |
58 | regulation of B cell mediated immunity (GO:0002712) | 3.45877135 |
59 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.38737578 |
60 | NIK/NF-kappaB signaling (GO:0038061) | 3.37705479 |
61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.35734096 |
62 | tolerance induction (GO:0002507) | 3.35522625 |
63 | myeloid dendritic cell activation (GO:0001773) | 3.35126576 |
64 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.33524193 |
65 | myeloid dendritic cell differentiation (GO:0043011) | 3.31004475 |
66 | positive regulation of tolerance induction (GO:0002645) | 3.30867319 |
67 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.29983784 |
68 | cytidine metabolic process (GO:0046087) | 3.24465801 |
69 | cytidine catabolic process (GO:0006216) | 3.24465801 |
70 | cytidine deamination (GO:0009972) | 3.24465801 |
71 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.23175244 |
72 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.22931226 |
73 | neutrophil activation (GO:0042119) | 3.21441815 |
74 | defense response to protozoan (GO:0042832) | 3.20934929 |
75 | regulation of tolerance induction (GO:0002643) | 3.20515500 |
76 | granulocyte activation (GO:0036230) | 3.20209874 |
77 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.19093863 |
78 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.18019319 |
79 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.17919012 |
80 | Peyers patch development (GO:0048541) | 3.17919012 |
81 | mature B cell differentiation involved in immune response (GO:0002313) | 3.17474839 |
82 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.17212136 |
83 | natural killer cell activation (GO:0030101) | 3.16569408 |
84 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.16227813 |
85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14561208 |
86 | response to peptidoglycan (GO:0032494) | 3.14426181 |
87 | positive regulation of B cell differentiation (GO:0045579) | 3.13649970 |
88 | mast cell activation involved in immune response (GO:0002279) | 3.12868469 |
89 | mast cell degranulation (GO:0043303) | 3.12868469 |
90 | B cell mediated immunity (GO:0019724) | 3.10922934 |
91 | leukocyte degranulation (GO:0043299) | 3.10205696 |
92 | response to protozoan (GO:0001562) | 3.10081151 |
93 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.09395783 |
94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08751905 |
95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07986009 |
96 | positive regulation of immunoglobulin production (GO:0002639) | 3.07923365 |
97 | negative regulation of interleukin-12 production (GO:0032695) | 3.07569952 |
98 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07458750 |
99 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.06620480 |
100 | regulation of cell killing (GO:0031341) | 3.05716150 |
101 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.01567928 |
102 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01095549 |
103 | lymph node development (GO:0048535) | 3.00902216 |
104 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.00743751 |
105 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.98839741 |
106 | response to type I interferon (GO:0034340) | 2.96273811 |
107 | cellular response to type I interferon (GO:0071357) | 2.95188372 |
108 | type I interferon signaling pathway (GO:0060337) | 2.95188372 |
109 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94911725 |
110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94869373 |
111 | regulation of immunoglobulin production (GO:0002637) | 2.93998984 |
112 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93679560 |
113 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93679560 |
114 | dendritic cell chemotaxis (GO:0002407) | 2.93670572 |
115 | negative regulation of adaptive immune response (GO:0002820) | 2.93329854 |
116 | response to muramyl dipeptide (GO:0032495) | 2.91842592 |
117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91650930 |
118 | regulation of chronic inflammatory response (GO:0002676) | 2.91473509 |
119 | positive regulation of cell killing (GO:0031343) | 2.90303287 |
120 | myeloid cell activation involved in immune response (GO:0002275) | 2.88534601 |
121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87382324 |
122 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.87010896 |
123 | positive regulation of interleukin-17 production (GO:0032740) | 2.86026445 |
124 | negative regulation of innate immune response (GO:0045824) | 2.85090982 |
125 | negative regulation of T cell apoptotic process (GO:0070233) | 2.84084946 |
126 | detection of bacterium (GO:0016045) | 2.81519351 |
127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79102382 |
128 | positive regulation of defense response to virus by host (GO:0002230) | 2.78377276 |
129 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77173777 |
130 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77173777 |
131 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77173777 |
132 | modulation by symbiont of host immune response (GO:0052553) | 2.77173777 |
133 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77173777 |
134 | modulation by symbiont of host defense response (GO:0052031) | 2.77173777 |
135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76085794 |
136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73305569 |
137 | regulation of alpha-beta T cell activation (GO:0046634) | 2.72370883 |
138 | detection of other organism (GO:0098543) | 2.70296436 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.03838354 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.64594701 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.87319995 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.17559644 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75448445 |
6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.41399598 |
7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.40637241 |
8 | * MYC_22102868_ChIP-Seq_BL_Human | 3.40032980 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.37628886 |
10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.35769590 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.22129644 |
12 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.15138158 |
13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.08941397 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.08683628 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.91624576 |
16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.87614500 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68899769 |
18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.56190281 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.51284616 |
20 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.45803538 |
21 | * MYB_26560356_Chip-Seq_TH1_Human | 2.44343021 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26727001 |
23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26509294 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26247398 |
25 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24102984 |
26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20627186 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18176931 |
28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17488491 |
29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12644963 |
30 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11024127 |
31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08961218 |
32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04846125 |
33 | MAF_26560356_Chip-Seq_TH2_Human | 1.98574997 |
34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96688445 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96387843 |
36 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90316137 |
37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.88844626 |
38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87622154 |
39 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87513474 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86455507 |
41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81773268 |
42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.80976942 |
43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80151221 |
44 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.79322045 |
45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79004427 |
46 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76171018 |
47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76129243 |
48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74952593 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74568840 |
50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67903134 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63897139 |
52 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58633609 |
53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57443086 |
54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48723452 |
55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.44671618 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40699171 |
57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39636405 |
58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37709423 |
59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37165213 |
60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36753300 |
61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35363345 |
62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32363640 |
63 | P68_20966046_ChIP-Seq_HELA_Human | 1.32259112 |
64 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31585687 |
65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28284196 |
66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.25027369 |
67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25007084 |
68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23941687 |
69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22616845 |
70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21157633 |
71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20093066 |
72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19847837 |
73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19589628 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17119150 |
75 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15777503 |
76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13445812 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12022281 |
78 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09018377 |
79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08877595 |
80 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08774965 |
81 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.08491665 |
82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08474582 |
83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07883191 |
84 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07382169 |
85 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05719087 |
86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04727128 |
87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03767185 |
88 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02314538 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01880401 |
90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01467166 |
91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00779652 |
92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.99860040 |
93 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99706348 |
94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98658347 |
95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98578880 |
96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98031891 |
97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97969238 |
98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97804966 |
99 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.96938878 |
100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95984919 |
101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95625672 |
102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95036147 |
103 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94669444 |
104 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94493761 |
105 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93708352 |
106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93529513 |
107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92435254 |
108 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89202610 |
109 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85487089 |
110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82156385 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81294152 |
112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81202370 |
113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81023717 |
114 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80295939 |
115 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.79662678 |
116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78464871 |
117 | P300_27268052_Chip-Seq_Bcells_Human | 0.77935866 |
118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77705426 |
119 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77058222 |
120 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74870486 |
121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73436038 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 4.38294800 |
2 | MP0001835_abnormal_antigen_presentation | 3.91057796 |
3 | MP0003763_abnormal_thymus_physiology | 3.89766088 |
4 | MP0000685_abnormal_immune_system | 3.79353256 |
5 | MP0001800_abnormal_humoral_immune | 3.30732493 |
6 | MP0001790_abnormal_immune_system | 3.29220796 |
7 | MP0005387_immune_system_phenotype | 3.29220796 |
8 | MP0009785_altered_susceptibility_to | 3.21988391 |
9 | MP0005000_abnormal_immune_tolerance | 2.97306373 |
10 | MP0002723_abnormal_immune_serum | 2.82944201 |
11 | MP0002420_abnormal_adaptive_immunity | 2.80746196 |
12 | MP0001819_abnormal_immune_cell | 2.78752877 |
13 | MP0002452_abnormal_antigen_presenting | 2.75499140 |
14 | MP0002398_abnormal_bone_marrow | 2.68590378 |
15 | MP0004510_myositis | 2.64399785 |
16 | MP0005025_abnormal_response_to | 2.57190156 |
17 | MP0003866_abnormal_defecation | 2.55102963 |
18 | MP0003436_decreased_susceptibility_to | 2.50436361 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.40407064 |
20 | MP0001873_stomach_inflammation | 2.37850980 |
21 | MP0003303_peritoneal_inflammation | 2.35086064 |
22 | MP0000716_abnormal_immune_system | 2.35039664 |
23 | MP0002166_altered_tumor_susceptibility | 2.24516252 |
24 | MP0006082_CNS_inflammation | 2.21730698 |
25 | MP0002405_respiratory_system_inflammati | 2.16684043 |
26 | MP0004859_abnormal_synaptic_plasticity | 2.09013899 |
27 | MP0002722_abnormal_immune_system | 2.08526573 |
28 | MP0000689_abnormal_spleen_morphology | 2.08326982 |
29 | MP0010155_abnormal_intestine_physiology | 2.05839568 |
30 | MP0009333_abnormal_splenocyte_physiolog | 2.05457015 |
31 | MP0002419_abnormal_innate_immunity | 1.96539156 |
32 | MP0000703_abnormal_thymus_morphology | 1.93940772 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.91843225 |
34 | MP0005464_abnormal_platelet_physiology | 1.91585700 |
35 | MP0002429_abnormal_blood_cell | 1.90677085 |
36 | MP0002006_tumorigenesis | 1.90414391 |
37 | MP0002396_abnormal_hematopoietic_system | 1.82527968 |
38 | MP0005310_abnormal_salivary_gland | 1.77201414 |
39 | MP0004947_skin_inflammation | 1.76033463 |
40 | MP0004808_abnormal_hematopoietic_stem | 1.63558212 |
41 | MP0001845_abnormal_inflammatory_respons | 1.62588485 |
42 | MP0001853_heart_inflammation | 1.56252155 |
43 | MP0003300_gastrointestinal_ulcer | 1.54740086 |
44 | MP0003880_abnormal_central_pattern | 1.53082057 |
45 | MP0005451_abnormal_body_composition | 1.47390056 |
46 | MP0009840_abnormal_foam_cell | 1.44424068 |
47 | MP0003724_increased_susceptibility_to | 1.43621633 |
48 | MP0002138_abnormal_hepatobiliary_system | 1.35694789 |
49 | MP0005058_abnormal_lysosome_morphology | 1.35693666 |
50 | MP0002933_joint_inflammation | 1.32400828 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.25524578 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.21298648 |
53 | MP0000490_abnormal_crypts_of | 1.18831128 |
54 | MP0005397_hematopoietic_system_phenotyp | 1.18022764 |
55 | MP0001545_abnormal_hematopoietic_system | 1.18022764 |
56 | MP0005174_abnormal_tail_pigmentation | 1.14983709 |
57 | MP0008569_lethality_at_weaning | 1.12085977 |
58 | MP0003635_abnormal_synaptic_transmissio | 1.11417726 |
59 | MP0001348_abnormal_lacrimal_gland | 1.11060618 |
60 | MP0005083_abnormal_biliary_tract | 1.09279230 |
61 | MP0004381_abnormal_hair_follicle | 1.05896837 |
62 | MP0001501_abnormal_sleep_pattern | 1.05793054 |
63 | MP0008469_abnormal_protein_level | 1.03651801 |
64 | MP0000858_altered_metastatic_potential | 0.98841518 |
65 | MP0003453_abnormal_keratinocyte_physiol | 0.98399484 |
66 | MP0001663_abnormal_digestive_system | 0.96071021 |
67 | MP0002139_abnormal_hepatobiliary_system | 0.94708704 |
68 | MP0001533_abnormal_skeleton_physiology | 0.94680059 |
69 | MP0008004_abnormal_stomach_pH | 0.94644139 |
70 | MP0009745_abnormal_behavioral_response | 0.93626571 |
71 | MP0003172_abnormal_lysosome_physiology | 0.93141204 |
72 | MP0003448_altered_tumor_morphology | 0.91763837 |
73 | MP0009763_increased_sensitivity_to | 0.89772210 |
74 | MP0000343_altered_response_to | 0.89193499 |
75 | MP0001851_eye_inflammation | 0.87357788 |
76 | MP0002009_preneoplasia | 0.87171035 |
77 | MP0005075_abnormal_melanosome_morpholog | 0.85567170 |
78 | MP0005166_decreased_susceptibility_to | 0.83793886 |
79 | MP0002064_seizures | 0.81754639 |
80 | MP0001986_abnormal_taste_sensitivity | 0.81403192 |
81 | MP0000604_amyloidosis | 0.80561545 |
82 | MP0005423_abnormal_somatic_nervous | 0.78954116 |
83 | MP0001968_abnormal_touch/_nociception | 0.78056845 |
84 | MP0002019_abnormal_tumor_incidence | 0.78027402 |
85 | MP0000015_abnormal_ear_pigmentation | 0.76964142 |
86 | MP0010234_abnormal_vibrissa_follicle | 0.73600222 |
87 | MP0003656_abnormal_erythrocyte_physiolo | 0.73565210 |
88 | MP0008260_abnormal_autophagy | 0.72695222 |
89 | MP0002063_abnormal_learning/memory/cond | 0.71560164 |
90 | MP0008961_abnormal_basal_metabolism | 0.71557201 |
91 | MP0008874_decreased_physiological_sensi | 0.69775915 |
92 | MP0002998_abnormal_bone_remodeling | 0.67723397 |
93 | MP0002822_catalepsy | 0.67718179 |
94 | MP0009764_decreased_sensitivity_to | 0.67510590 |
95 | MP0000249_abnormal_blood_vessel | 0.66480163 |
96 | MP0003828_pulmonary_edema | 0.66404956 |
97 | MP0003329_amyloid_beta_deposits | 0.64844604 |
98 | MP0002095_abnormal_skin_pigmentation | 0.64839568 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64082582 |
100 | MP0003045_fibrosis | 0.63833472 |
101 | MP0000609_abnormal_liver_physiology | 0.63368964 |
102 | MP0002132_abnormal_respiratory_system | 0.62458348 |
103 | MP0008872_abnormal_physiological_respon | 0.61101009 |
104 | MP0001765_abnormal_ion_homeostasis | 0.60953955 |
105 | MP0002735_abnormal_chemical_nociception | 0.60643733 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.60428516 |
107 | MP0002136_abnormal_kidney_physiology | 0.59034399 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.58463145 |
109 | MP0009643_abnormal_urine_homeostasis | 0.58341354 |
110 | MP0002572_abnormal_emotion/affect_behav | 0.57704772 |
111 | MP0009765_abnormal_xenobiotic_induced | 0.57011024 |
112 | MP0002736_abnormal_nociception_after | 0.56917152 |
113 | MP0005410_abnormal_fertilization | 0.55721129 |
114 | MP0008873_increased_physiological_sensi | 0.55600100 |
115 | MP0005390_skeleton_phenotype | 0.55541622 |
116 | MP0003075_altered_response_to | 0.55493276 |
117 | MP0003795_abnormal_bone_structure | 0.53269543 |
118 | MP0008875_abnormal_xenobiotic_pharmacok | 0.53162968 |
119 | MP0005167_abnormal_blood-brain_barrier | 0.52827186 |
120 | MP0001919_abnormal_reproductive_system | 0.52599434 |
121 | MP0003879_abnormal_hair_cell | 0.52166883 |
122 | MP0003183_abnormal_peptide_metabolism | 0.51430401 |
123 | MP0002909_abnormal_adrenal_gland | 0.51307622 |
124 | MP0002733_abnormal_thermal_nociception | 0.49322888 |
125 | MP0001970_abnormal_pain_threshold | 0.47800548 |
126 | MP0002083_premature_death | 0.46541445 |
127 | MP0002272_abnormal_nervous_system | 0.45755941 |
128 | MP0004270_analgesia | 0.45482690 |
129 | MP0009278_abnormal_bone_marrow | 0.44866938 |
130 | MP0000477_abnormal_intestine_morphology | 0.44638370 |
131 | MP0003943_abnormal_hepatobiliary_system | 0.44452246 |
132 | MP0002693_abnormal_pancreas_physiology | 0.44348167 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bronchitis (HP:0002837) | 5.01128845 |
2 | T lymphocytopenia (HP:0005403) | 4.99158945 |
3 | Abnormality of T cell number (HP:0011839) | 4.86970752 |
4 | IgM deficiency (HP:0002850) | 4.72643883 |
5 | Chronic otitis media (HP:0000389) | 4.66073206 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.65475769 |
7 | Stomatitis (HP:0010280) | 4.56162251 |
8 | Myositis (HP:0100614) | 4.54332076 |
9 | Nasal polyposis (HP:0100582) | 4.28186279 |
10 | Recurrent fungal infections (HP:0002841) | 4.19173064 |
11 | Abnormality of T cells (HP:0002843) | 4.16314707 |
12 | Agammaglobulinemia (HP:0004432) | 4.09635799 |
13 | Panhypogammaglobulinemia (HP:0003139) | 3.94474153 |
14 | Eczematoid dermatitis (HP:0000976) | 3.93179091 |
15 | Recurrent viral infections (HP:0004429) | 3.85203660 |
16 | Retrobulbar optic neuritis (HP:0100654) | 3.76688367 |
17 | Optic neuritis (HP:0100653) | 3.76688367 |
18 | IgG deficiency (HP:0004315) | 3.76607372 |
19 | Abnormality of the nasal mucosa (HP:0000433) | 3.75569828 |
20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75257848 |
21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75257848 |
22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72483542 |
23 | Severe combined immunodeficiency (HP:0004430) | 3.69656576 |
24 | Recurrent abscess formation (HP:0002722) | 3.62230887 |
25 | Thrombocytosis (HP:0001894) | 3.51694271 |
26 | Lymphopenia (HP:0001888) | 3.48779894 |
27 | Meningitis (HP:0001287) | 3.43723116 |
28 | Vasculitis (HP:0002633) | 3.39268172 |
29 | Combined immunodeficiency (HP:0005387) | 3.36790599 |
30 | Orchitis (HP:0100796) | 3.35945191 |
31 | Thyroiditis (HP:0100646) | 3.34963720 |
32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.34336234 |
33 | Autoimmune hemolytic anemia (HP:0001890) | 3.34199450 |
34 | Gastrointestinal stroma tumor (HP:0100723) | 3.24523512 |
35 | Abnormality of T cell physiology (HP:0011840) | 3.13445444 |
36 | Recurrent sinusitis (HP:0011108) | 3.08837172 |
37 | Chronic sinusitis (HP:0011109) | 3.05473017 |
38 | Fatigue (HP:0012378) | 3.01453301 |
39 | Mediastinal lymphadenopathy (HP:0100721) | 3.01096052 |
40 | Recurrent bacterial skin infections (HP:0005406) | 3.00701145 |
41 | Abnormality of B cell number (HP:0010975) | 2.96744083 |
42 | B lymphocytopenia (HP:0010976) | 2.96744083 |
43 | Increased IgM level (HP:0003496) | 2.95443696 |
44 | Recurrent skin infections (HP:0001581) | 2.89421079 |
45 | Chronic diarrhea (HP:0002028) | 2.89023194 |
46 | Bronchitis (HP:0012387) | 2.87300320 |
47 | Gastrointestinal inflammation (HP:0004386) | 2.87237931 |
48 | Cellulitis (HP:0100658) | 2.86092122 |
49 | Inflammation of the large intestine (HP:0002037) | 2.83609627 |
50 | Autoimmune thrombocytopenia (HP:0001973) | 2.83321213 |
51 | Encephalitis (HP:0002383) | 2.76292879 |
52 | Abnormality of eosinophils (HP:0001879) | 2.76275098 |
53 | Prolonged bleeding time (HP:0003010) | 2.70607297 |
54 | Arterial thrombosis (HP:0004420) | 2.69534505 |
55 | Abnormality of macrophages (HP:0004311) | 2.66634838 |
56 | Pulmonary infiltrates (HP:0002113) | 2.66589852 |
57 | Increased serum ferritin (HP:0003281) | 2.66297994 |
58 | Increased IgE level (HP:0003212) | 2.65310919 |
59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63827690 |
60 | Obstructive lung disease (HP:0006536) | 2.63827690 |
61 | IgA deficiency (HP:0002720) | 2.63334297 |
62 | Progressive inability to walk (HP:0002505) | 2.61908055 |
63 | Leukocytosis (HP:0001974) | 2.59413948 |
64 | Hemoptysis (HP:0002105) | 2.57622026 |
65 | Joint swelling (HP:0001386) | 2.51809198 |
66 | Pustule (HP:0200039) | 2.51508684 |
67 | Verrucae (HP:0200043) | 2.50693444 |
68 | Papilloma (HP:0012740) | 2.50693444 |
69 | Colitis (HP:0002583) | 2.48853601 |
70 | Chest pain (HP:0100749) | 2.47043636 |
71 | Gastrointestinal infarctions (HP:0005244) | 2.41783024 |
72 | Epistaxis (HP:0000421) | 2.41775648 |
73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41655886 |
74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41655886 |
75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41655886 |
76 | Keratoconjunctivitis sicca (HP:0001097) | 2.38903052 |
77 | Diplopia (HP:0000651) | 2.37288982 |
78 | Abnormality of binocular vision (HP:0011514) | 2.37288982 |
79 | Petechiae (HP:0000967) | 2.37129381 |
80 | Hypergammaglobulinemia (HP:0010702) | 2.35412922 |
81 | Lymphoma (HP:0002665) | 2.34224420 |
82 | Acute hepatic failure (HP:0006554) | 2.29042711 |
83 | Anorexia (HP:0002039) | 2.28766302 |
84 | Abnormality of iron homeostasis (HP:0011031) | 2.28257764 |
85 | Dyschromatopsia (HP:0007641) | 2.27084990 |
86 | Urticaria (HP:0001025) | 2.26522270 |
87 | Abnormal platelet volume (HP:0011876) | 2.24640051 |
88 | Hypertensive crisis (HP:0100735) | 2.23918906 |
89 | Hemorrhage of the eye (HP:0011885) | 2.22843309 |
90 | Interstitial pulmonary disease (HP:0006530) | 2.22114157 |
91 | Hepatosplenomegaly (HP:0001433) | 2.22071660 |
92 | Emphysema (HP:0002097) | 2.19905705 |
93 | Abnormality of the prostate (HP:0008775) | 2.19182535 |
94 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19087156 |
95 | Amaurosis fugax (HP:0100576) | 2.18499574 |
96 | Menorrhagia (HP:0000132) | 2.17546355 |
97 | Keratoconjunctivitis (HP:0001096) | 2.14038859 |
98 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12910420 |
99 | Eosinophilia (HP:0001880) | 2.03633456 |
100 | Dysostosis multiplex (HP:0000943) | 2.01433408 |
101 | Visual hallucinations (HP:0002367) | 2.00238433 |
102 | Abnormality of the fingertips (HP:0001211) | 1.97884911 |
103 | Increased cerebral lipofuscin (HP:0011813) | 1.96400008 |
104 | Gangrene (HP:0100758) | 1.96077898 |
105 | Vacuolated lymphocytes (HP:0001922) | 1.95477960 |
106 | Papilledema (HP:0001085) | 1.93676426 |
107 | Aplastic anemia (HP:0001915) | 1.93044820 |
108 | Increased muscle lipid content (HP:0009058) | 1.92568485 |
109 | Spontaneous hematomas (HP:0007420) | 1.91965219 |
110 | Abnormal platelet function (HP:0011869) | 1.90858963 |
111 | Impaired platelet aggregation (HP:0003540) | 1.90858963 |
112 | Joint hemorrhage (HP:0005261) | 1.90429885 |
113 | Focal motor seizures (HP:0011153) | 1.89572516 |
114 | Poikiloderma (HP:0001029) | 1.89470073 |
115 | Purpura (HP:0000979) | 1.88423762 |
116 | Hypochromic anemia (HP:0001931) | 1.87471617 |
117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86852570 |
118 | Granulocytopenia (HP:0001913) | 1.86446485 |
119 | Restrictive lung disease (HP:0002091) | 1.85708672 |
120 | Basal cell carcinoma (HP:0002671) | 1.85321194 |
121 | Hypoplasia of the thymus (HP:0000778) | 1.84332711 |
122 | Gingival bleeding (HP:0000225) | 1.83983481 |
123 | Arthralgia (HP:0002829) | 1.83206215 |
124 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83194787 |
125 | Recurrent otitis media (HP:0000403) | 1.82845025 |
126 | Sepsis (HP:0100806) | 1.79070867 |
127 | Bronchiectasis (HP:0002110) | 1.74550157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.66177956 |
2 | TXK | 4.06093840 |
3 | JAK3 | 3.13476944 |
4 | ZAP70 | 2.66414570 |
5 | TAOK3 | 2.65098822 |
6 | MAP3K12 | 2.59841003 |
7 | MAP3K13 | 2.56109361 |
8 | IKBKE | 2.30112219 |
9 | GRK6 | 2.29128763 |
10 | RIPK4 | 2.25352324 |
11 | SYK | 2.19307485 |
12 | TBK1 | 2.13386792 |
13 | ITK | 2.05679643 |
14 | PRPF4B | 1.97348336 |
15 | MAP3K14 | 1.96103172 |
16 | TYK2 | 1.91013711 |
17 | FES | 1.88195140 |
18 | TAOK1 | 1.83652375 |
19 | ERN1 | 1.81168870 |
20 | BTK | 1.77858484 |
21 | BLK | 1.77681217 |
22 | MAP3K9 | 1.77521624 |
23 | JAK1 | 1.76583537 |
24 | EEF2K | 1.66650139 |
25 | KIT | 1.64788262 |
26 | TEC | 1.60409196 |
27 | LCK | 1.56096048 |
28 | IKBKB | 1.48489019 |
29 | SIK2 | 1.47561062 |
30 | STK10 | 1.44510170 |
31 | CDK19 | 1.42426515 |
32 | MST1R | 1.38236896 |
33 | RAF1 | 1.37530304 |
34 | HCK | 1.36779838 |
35 | MST4 | 1.36381374 |
36 | NLK | 1.31457613 |
37 | MAP3K3 | 1.29991758 |
38 | CSK | 1.26965146 |
39 | TNK2 | 1.23900899 |
40 | TLK1 | 1.22506150 |
41 | KSR2 | 1.20412567 |
42 | IRAK4 | 1.17918851 |
43 | NME2 | 1.14950018 |
44 | FGFR4 | 1.13929194 |
45 | ARAF | 1.11287811 |
46 | SMG1 | 1.09153242 |
47 | MAP2K3 | 1.06844629 |
48 | VRK2 | 1.06802671 |
49 | SIK3 | 1.04277909 |
50 | LRRK2 | 1.01112182 |
51 | MAP3K11 | 0.99470793 |
52 | EPHA2 | 0.97900788 |
53 | LYN | 0.96948598 |
54 | PRKCQ | 0.93679217 |
55 | PRKCH | 0.92163418 |
56 | PIM2 | 0.84478063 |
57 | KDR | 0.82501120 |
58 | GRK7 | 0.81482148 |
59 | NTRK3 | 0.80806832 |
60 | FGFR3 | 0.80005511 |
61 | SIK1 | 0.79650767 |
62 | MAP2K6 | 0.79381921 |
63 | DAPK1 | 0.79198301 |
64 | CHUK | 0.78096743 |
65 | CSF1R | 0.77086200 |
66 | MAPK11 | 0.76429351 |
67 | MAP2K7 | 0.76361058 |
68 | JAK2 | 0.75452726 |
69 | TESK2 | 0.74457254 |
70 | PIM1 | 0.74087288 |
71 | MAP3K10 | 0.74076548 |
72 | ALK | 0.73584979 |
73 | MAP3K7 | 0.73280171 |
74 | BMX | 0.72367889 |
75 | MAP3K1 | 0.69452157 |
76 | IRAK2 | 0.69135456 |
77 | TGFBR2 | 0.68831662 |
78 | CAMKK2 | 0.67962745 |
79 | PRKD2 | 0.67109590 |
80 | PDK1 | 0.65844845 |
81 | TNIK | 0.64098509 |
82 | CDK4 | 0.59786465 |
83 | CLK1 | 0.59042129 |
84 | MARK2 | 0.58927909 |
85 | PDPK1 | 0.56457548 |
86 | TGFBR1 | 0.56211848 |
87 | PKN2 | 0.54399886 |
88 | CAMKK1 | 0.52408589 |
89 | EPHB1 | 0.51137113 |
90 | MAP2K2 | 0.51133773 |
91 | BMPR2 | 0.50288367 |
92 | BCKDK | 0.49792111 |
93 | MUSK | 0.49473905 |
94 | MAPKAPK2 | 0.48841780 |
95 | MAPK15 | 0.48460480 |
96 | RET | 0.47571971 |
97 | MAP3K5 | 0.46909680 |
98 | FYN | 0.44066249 |
99 | MARK3 | 0.43763243 |
100 | MELK | 0.43418318 |
101 | MAPK12 | 0.43331768 |
102 | FGR | 0.40462997 |
103 | HIPK2 | 0.40112561 |
104 | TESK1 | 0.39369108 |
105 | STK24 | 0.38805759 |
106 | ADRBK2 | 0.38481738 |
107 | NTRK2 | 0.38318655 |
108 | PAK1 | 0.37535432 |
109 | CAMK1 | 0.37247913 |
110 | PAK4 | 0.36946625 |
111 | MAP3K4 | 0.36819184 |
112 | PRKG2 | 0.36502089 |
113 | MATK | 0.36314059 |
114 | SCYL2 | 0.36313164 |
115 | CDK5 | 0.33022427 |
116 | STK11 | 0.32886713 |
117 | MINK1 | 0.32662118 |
118 | MAPKAPK3 | 0.30895242 |
119 | GRK5 | 0.29250267 |
120 | PASK | 0.28784920 |
121 | ZAK | 0.27930138 |
122 | IRAK3 | 0.27647021 |
123 | CDK6 | 0.25850318 |
124 | PTK2B | 0.25403217 |
125 | KSR1 | 0.24977124 |
126 | PRKCD | 0.24218459 |
127 | MAPK4 | 0.21938841 |
128 | IRAK1 | 0.21937358 |
129 | TAOK2 | 0.21519162 |
130 | TRIB3 | 0.20931710 |
131 | DAPK3 | 0.20430005 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.15169032 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.77107179 |
3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.73795145 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.64373445 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.61027570 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54657506 |
7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39370612 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34963778 |
9 | Measles_Homo sapiens_hsa05162 | 2.09805964 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00286414 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.97427161 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83700411 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82380600 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81146764 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76357476 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69654840 |
17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66383833 |
18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62660594 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59344314 |
20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57279877 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50192965 |
22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49172506 |
23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42824538 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39996133 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39605319 |
26 | Shigellosis_Homo sapiens_hsa05131 | 1.39225116 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33290083 |
28 | Asthma_Homo sapiens_hsa05310 | 1.30601105 |
29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29993178 |
30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29085951 |
31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24995706 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15760784 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14113556 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13057925 |
35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12039269 |
36 | Ribosome_Homo sapiens_hsa03010 | 1.11851416 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11800403 |
38 | Platelet activation_Homo sapiens_hsa04611 | 1.10454104 |
39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10361213 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.07222328 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.05228789 |
42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02415675 |
43 | Influenza A_Homo sapiens_hsa05164 | 1.02354204 |
44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00098925 |
45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97068048 |
46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95324331 |
47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95161210 |
48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92644828 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 0.91462681 |
50 | Lysosome_Homo sapiens_hsa04142 | 0.89645738 |
51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88370733 |
52 | Apoptosis_Homo sapiens_hsa04210 | 0.87950810 |
53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87902042 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86717780 |
55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83939335 |
56 | Proteasome_Homo sapiens_hsa03050 | 0.83221124 |
57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82122683 |
58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81843409 |
59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81470089 |
60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79449393 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78177425 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77370379 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76424276 |
64 | Pertussis_Homo sapiens_hsa05133 | 0.74799013 |
65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73583896 |
66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72532269 |
67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.71328638 |
68 | Morphine addiction_Homo sapiens_hsa05032 | 0.70343515 |
69 | Malaria_Homo sapiens_hsa05144 | 0.68317575 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68182125 |
71 | Legionellosis_Homo sapiens_hsa05134 | 0.67878774 |
72 | Hepatitis C_Homo sapiens_hsa05160 | 0.67089855 |
73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66913539 |
74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65891526 |
75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65322625 |
76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64715705 |
77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64612024 |
78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64266867 |
79 | Salivary secretion_Homo sapiens_hsa04970 | 0.63351139 |
80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62866131 |
81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62352930 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61812028 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.61474689 |
84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60075432 |
85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59692111 |
86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58781897 |
87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58530967 |
88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58330760 |
89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56259568 |
90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56135806 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.55704119 |
92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55132297 |
93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55013196 |
94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54941174 |
95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53374127 |
96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52075335 |
97 | Renin secretion_Homo sapiens_hsa04924 | 0.51905596 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51425404 |
99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48665711 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48144745 |
101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47025693 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46376437 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45161898 |
104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44902783 |
105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43737709 |
106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43279688 |
107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42902084 |
108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42804697 |
109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42802304 |
110 | Long-term depression_Homo sapiens_hsa04730 | 0.42216044 |
111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40131089 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40041415 |
113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39794260 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39338119 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35974131 |
116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32022081 |
117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30648604 |
118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26965667 |
119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26461512 |
120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24630278 |
121 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24610844 |
122 | Insulin resistance_Homo sapiens_hsa04931 | 0.23975677 |
123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21763993 |
124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16203934 |
125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13127069 |
126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.12481292 |
127 | Bladder cancer_Homo sapiens_hsa05219 | 0.12204802 |
128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10272054 |
129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09631197 |